I have a huge problem with the concept of DBT, with regards to trying to determine the differences or lack there of, with audio products. Maybe I'm just slow but, I often have to live a piece of gear for awhile before I can really tell what it can and cannot do.
DBT is great for something like a new medicine. However, it would be worthless if you gave the subjects one pill, one time. The studies take place over a period of time. And that is the problem with DBT in audio. You sit a group of people in front of the setup. They listen to a couple of songs, you switch whatever component and then play a couple of songs. That just doesn't work. The differences are often very subtle and can't be heard a first.
Which, of course, is the dilemma of making a new purchase. You have to base your decision on short listening periods.
The concept of a DBT for a audio component is great. But, I have yet to see how a test would be set up that would be of any value. Looking a test results based on swapping components after short listening periods would never influence my buying decisions. I wouldn't care how large the audience was or how many times it was repeated. Anymore than I would trust a new drug that was conducted with a one pill dose.
DBT is great for something like a new medicine. However, it would be worthless if you gave the subjects one pill, one time. The studies take place over a period of time. And that is the problem with DBT in audio. You sit a group of people in front of the setup. They listen to a couple of songs, you switch whatever component and then play a couple of songs. That just doesn't work. The differences are often very subtle and can't be heard a first.
Which, of course, is the dilemma of making a new purchase. You have to base your decision on short listening periods.
The concept of a DBT for a audio component is great. But, I have yet to see how a test would be set up that would be of any value. Looking a test results based on swapping components after short listening periods would never influence my buying decisions. I wouldn't care how large the audience was or how many times it was repeated. Anymore than I would trust a new drug that was conducted with a one pill dose.